Pengfei Yu

4.1k total citations
137 papers, 2.9k citations indexed

About

Pengfei Yu is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pengfei Yu has authored 137 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Surgery, 42 papers in Molecular Biology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pengfei Yu's work include Gastric Cancer Management and Outcomes (23 papers), Spine and Intervertebral Disc Pathology (18 papers) and Metastasis and carcinoma case studies (13 papers). Pengfei Yu is often cited by papers focused on Gastric Cancer Management and Outcomes (23 papers), Spine and Intervertebral Disc Pathology (18 papers) and Metastasis and carcinoma case studies (13 papers). Pengfei Yu collaborates with scholars based in China, United States and Japan. Pengfei Yu's co-authors include Yian Du, Ling Huang, Xiangdong Cheng, Qingchuan Zhao, Litao Yang, Kazumi Yagasaki, Qi Yu, Zhiyuan Xu, Shiqi Wang and Hongwei� Jiang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Pengfei Yu

128 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengfei Yu China 27 1.2k 795 726 593 439 137 2.9k
Bicheng Chen China 31 1.6k 1.4× 828 1.0× 567 0.8× 792 1.3× 432 1.0× 129 3.3k
Jung Han Kim South Korea 31 1.1k 0.9× 642 0.8× 962 1.3× 465 0.8× 337 0.8× 150 3.4k
Zheng Wu China 34 1.4k 1.2× 657 0.8× 996 1.4× 825 1.4× 448 1.0× 149 3.2k
Jian Dong China 26 939 0.8× 454 0.6× 586 0.8× 527 0.9× 265 0.6× 96 2.4k
Satoshi Kobayashi Japan 30 1.0k 0.9× 768 1.0× 1.1k 1.6× 255 0.4× 326 0.7× 213 3.3k
Graham P. Pidgeon Ireland 29 1.0k 0.9× 456 0.6× 635 0.9× 656 1.1× 221 0.5× 65 2.7k
Bo Jiang China 28 879 0.8× 775 1.0× 832 1.1× 359 0.6× 184 0.4× 188 2.9k
Yasuyoshi Miyata Japan 33 1.5k 1.3× 542 0.7× 641 0.9× 608 1.0× 122 0.3× 174 3.3k
Shigemi Matsumoto Japan 26 866 0.7× 557 0.7× 1.6k 2.2× 380 0.6× 263 0.6× 136 3.2k
Masaru Harada Japan 31 1.1k 1.0× 655 0.8× 627 0.9× 294 0.5× 1.3k 2.8× 198 4.0k

Countries citing papers authored by Pengfei Yu

Since Specialization
Citations

This map shows the geographic impact of Pengfei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Yu more than expected).

Fields of papers citing papers by Pengfei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Yu. The network helps show where Pengfei Yu may publish in the future.

Co-authorship network of co-authors of Pengfei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Yu. A scholar is included among the top collaborators of Pengfei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Yu. Pengfei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Pengfei, et al.. (2025). Value of contrast-enhanced MRI for predicting resorption of ruptured lumbar disc herniation: a prospective study of 82 cases. Journal of Orthopaedic Surgery and Research. 20(1). 1006–1006.
3.
Bu, Fanqin, Guangyu Ding, Lin Yang, et al.. (2025). Lectin-affinity glycosylation pattern analysis of plasma extracellular vesicles: An all-in-one clinical assessment for gastric cancer diagnosis and treatment. Cancer Letters. 631. 217929–217929. 1 indexed citations
4.
Wang, Zhiqiang, Xiaochun Li, Pengfei Yu, et al.. (2024). Role of Autophagy and Pyroptosis in Intervertebral Disc Degeneration. Journal of Inflammation Research. Volume 17. 91–100. 14 indexed citations
5.
Wang, Zhiqiang, Xiaochun Li, Pengfei Yu, et al.. (2024). Protective effects of Gumibao recipe on glucocorticoid-included bone microcirculatory endothelial cell injury and the underlying mechanism. International Immunopharmacology. 142(Pt A). 112989–112989.
6.
Yang, Junjie, Jiayu Liu, Guohao Liu, et al.. (2024). Celastrol Regulates the Hsp90-NLRP3 Interaction to Alleviate Rheumatoid Arthritis. Inflammation. 48(1). 346–360. 8 indexed citations
7.
Yu, Pengfei, et al.. (2024). Tim-1-mediated extracellular matrix promotes the development of hepatocellular carcinoma. Acta Biochimica et Biophysica Sinica. 56(12). 1761–1773.
8.
Lu, Xinliang, Zhengbo Song, Xianghui Kong, et al.. (2024). Proton pump inhibitors enhance macropinocytosis‐mediated extracellular vesicle endocytosis by inducing membrane v‐ATPase assembly. Journal of Extracellular Vesicles. 13(4). e12426–e12426. 14 indexed citations
9.
Ma, Xiaoying, Jingyun Chen, Hongwei Li, et al.. (2022). Traditional Chinese medicine promotes the resorption of herniated intervertebral discs by regulating autophagy and apoptosis. Pharmacological Research - Modern Chinese Medicine. 3. 100112–100112. 2 indexed citations
10.
Shen, Xiaofeng, Xiaochen Sun, Hua Chen, et al.. (2021). Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition. Cancer Chemotherapy and Pharmacology. 87(4). 487–499. 10 indexed citations
11.
Qiu, Meihua, et al.. (2021). Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respiratory Research. 22(1). 264–264. 34 indexed citations
13.
Shen, Xiaofeng, Pengfei Yu, Hua Chen, et al.. (2020). Icariin controlled release on a silk fibroin/mesoporous bioactive glass nanoparticles scaffold for promoting stem cell osteogenic differentiation. RSC Advances. 10(20). 12105–12112. 20 indexed citations
14.
Wang, Shiqi, Quan Wang, Lei Xu, et al.. (2020). Beware Pathological Findings of the Stomach in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis. Obesity Surgery. 31(1). 337–342. 11 indexed citations
15.
Wang, Shiqi, Lei Xu, Quan Wang, et al.. (2019). Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World Journal of Surgical Oncology. 17(1). 52–52. 92 indexed citations
16.
Yu, Pengfei, et al.. (2019). PCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrations. Scientific Reports. 9(1). 5692–5692. 19 indexed citations
17.
Wang, Shiqi, Lin Shang, Hu Wang, et al.. (2018). Reconstruction methods after radical proximal gastrectomy. Medicine. 97(11). e0121–e0121. 38 indexed citations
18.
Liu, Jintao, et al.. (2017). Incidence of Spontaneous Resorption of Lumbar Disc Herniation: A Meta-Analysis.. PubMed. 20(1). E45–E52. 63 indexed citations
19.
Yu, Pengfei, Shiqi Wang, Zhaoyan Qiu, et al.. (2016). Efficacy of resistin and leptin in predicting persistent organ failure in patients with acute pancreatitis. Pancreatology. 16(6). 952–957. 14 indexed citations
20.
Yu, Pengfei, Liang Ye, Hongbo Wang, et al.. (2014). NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis. PLoS ONE. 9(12). e115041–e115041. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026